Evidence map›Paper›PMID 41087322›Full record

ArticleJournal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology2025

Prognostic Significance of a Novel Histopathologic Risk Model Incorporating Modifications to the Worst Pattern of Invasion and Tumor Budding for Oral Squamous Cell Carcinoma.

Everton Freitas de Morais, Lívia Maris Ribeiro Paranaiba Dias, Ana Lúcia Carrinho Ayroza Rangel, Ricardo D Coletta

Abstract read
In one paragraph

Article in Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Prognostic Significance of a Novel Histopathologic Risk Model Incorporating Modifications to the Worst Pattern of Invasion and Tumor Budding for Oral Squamous Cell Carcinoma.Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Everton Freitas de MoraisGraduate Program in Oral Biology, Piracicaba Dental School, University of Campinas, Piracicaba, São Paulo, Brazil.
Lívia Maris Ribeiro Paranaiba DiasDepartment of Oral Diagnosis, Piracicaba Dental School, University of Campinas, Piracicaba, São Paulo, Brazil.
Ana Lúcia Carrinho Ayroza RangelCenter of Biological Sciences and of the Health, School of Dentistry, State University of Western Paraná, Cascavel, Paraná, Brazil.
Ricardo D ColettaGraduate Program in Oral Biology, Piracicaba Dental School, University of Campinas, Piracicaba, São Paulo, Brazil.

Funding

Minas Gerais State Research Funding Foundation (FAPEMIG) #2022/00994-5National Council for Scientific and Technological Development (CNPq) #303589/2019-1São Paulo Research Foundation (FAPESP) PPM-00179-18
6 · The paper itself

Abstract

backgroundPrognostic stratification to predict patient outcomes and guide treatment decisions is urgently needed to improve clinical management of oral squamous cell carcinoma (OSCC). This study evaluated the prognostic performance of a novel histopathologic risk model that integrates modifications to the worst pattern of invasion (WPOI) system and tumor budding (TB) classification for OSCC, focusing on its effectiveness in predicting recurrence and survival.

methodsIn a retrospective study of 193 OSCC cases, the modifications incorporated to the WPOI and TB were initially compared to conventional assessments. Next, the effectiveness of the novel histopathologic risk model was assessed. Univariate and multivariate survival analyses were performed using Cox proportional hazards models. The performance of the classifiers was evaluated by applying the receiver operating characteristic (ROC) analysis, calculating the area under the curve (AUC).

resultsClassical WPOI was significantly and independently associated with shortened cancer-specific survival (HR = 2.0, 95% CI = 1.26-3.25, p = 0.003); whereas classical TB was associated with poor disease-free survival (HR = 2.17, 95% CI = 1.25-3.74, p = 0.005). In contrast, the modified WPOI and TB showed no significant associations with patient outcomes. The novel histopathologic risk model, which categorized 68.4% of cases as intermediate risk, showed limited ability to predict OSCC outcomes.

conclusionsThe findings of this study show the superior prognostic value of the classical WPOI and TB over their modified counterparts; the potential of the novel histopathologic risk was not validated in this cohort including OSCCs at all clinical stages.

Indexed as

Carcinoma, Squamous CellMouth NeoplasmsAdultAgedAged, 80 and overDisease-Free SurvivalFemaleHumansMaleMiddle AgedNeoplasm InvasivenessNeoplasm Recurrence, LocalPrognosisRetrospective StudiesRisk Assessmenthistopathologic risk modeloral cancerprognosistumor buddingworst pattern of invasion

Identifiers

PMID41087322
PMCPMC12521064

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.